These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 2292525

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers.
    Nix DE, Symonds WT, Hyatt JM, Wilton JH, Teal MA, Reidenberg P, Affrime MB.
    Pharmacotherapy; 1997; 17(1):121-5. PubMed ID: 9017772
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Oral cephalosporins.
    Verhaegen J, Verbist L.
    Acta Clin Belg; 1992; 47(6):377-86. PubMed ID: 1337810
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Liquid-chromatographic determination of five orally active cephalosporins--cefixime, cefaclor, cefadroxil, cephalexin, and cephradine--in human serum.
    McAteer JA, Hiltke MF, Silber BM, Faulkner RD.
    Clin Chem; 1987 Oct; 33(10):1788-90. PubMed ID: 3665031
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A critical review of the new oral cephalosporins. Considerations and place in therapy.
    Rodman DP, McKnight JT, Anderson RL.
    Arch Fam Med; 1994 Nov; 3(11):975-80. PubMed ID: 7804480
    [Abstract] [Full Text] [Related]

  • 15. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients.
    Fulton B, Perry CM.
    Paediatr Drugs; 2001 Nov; 3(2):137-58. PubMed ID: 11269640
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections].
    Xiao YH, Gao L, Li Y, Lü Y, Liu J, Liu Y.
    Zhonghua Yi Xue Za Zhi; 2004 Nov 17; 84(22):1867-71. PubMed ID: 15631795
    [Abstract] [Full Text] [Related]

  • 19. Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
    Frampton JE, Brogden RN, Langtry HD, Buckley MM.
    Drugs; 1992 Nov 17; 44(5):889-917. PubMed ID: 1280571
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.